Epidemiology
Last updated: 2024 May 18
Total hit(s): 25281
S.No.
1
38658178
Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemic.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38757631
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38445561
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic period.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
38563792
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
5
38622888
SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020-2023.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
6
38439589
COVID-19 vaccine hesitancy among the Chinese elderly: A multi-stakeholder qualitative study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
7
38517220
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
8
38374618
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
9
38497583
Real-life experience on COVID-19 and seasonal influenza vaccines co-administration in the vaccination hub of the University Hospital of Palermo, Italy.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
10
38445666
Factors influencing adverse events following COVID-19 vaccination.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
11
38214317
How urban versus rural population relates to COVID-19 booster vaccine hesitancy: A propensity score matching design study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
12
38575149
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
13
38584120
Misinformation and COVID-19 vaccine uptake hesitancy among frontline workers in Tanzania: Do demographic variables matter?
Hum Vaccin Immunother
2024 Dec 31
4.7
1
14
38289323
Individual predictors of vaccine hesitancy in the Italian post COVID-19 pandemic era.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
15
38299510
Changes of influenza vaccination rate and associated influencing factors after the COVID-19 pandemic in Shanghai, China.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
16
38724010
Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
17
38191194
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
18
38282324
The impact of risk perception and institutional trust on COVID-19 vaccine hesitancy in China.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
19
38359815
Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
20
38299507
The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
21
38390696
The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
22
38407171
Politics and confidence toward the COVID-19 vaccination: A Brazilian cross-sectional study.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
23
38752704
Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported cases.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
24
38626299
Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
N/A
25
38407186
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data.
Hum Vaccin Immunother
2024 Dec 31
4.7
1